Homologous Recombination in Thyroid Tumor Samples
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26199716 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Liudmila V Spirina und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry and Molecular Biology Division, Siberian State Medical University, 2 Moskovsky Trakt, Tomsk 634050, Russia. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Homologous Recombination, Thyroid Cancer, Papillary. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Russian Science Foundation, Russian Science Foundation.
Abstract (Originalsprache)
Genomic studies have provided key insights into the molecular pathogenesis of differentiated thyroid carcinoma (DTC), including the role of genes involved in the homologous recombination (HR) related to DNA repair and genomic stability. This research aimed to investigate the genetic landscape of HR genes in thyroid pathology, associated with recurrence risk and clinical prognosis. The study involved six individuals with thyroid conditions, including two patients diagnosed with papillary thyroid carcinoma (PTC) and four individuals with benign thyroid disease. The research material consisted of tumor samples collected during surgical procedures. Protein interactions were analyzed using the STRING database (string-db.org). Homologous recombination genes were sequenced using the HRR Panel vr1.0 on the MiSeq™ Sequencing System. Bioinformatics analysis revealed a relationship between BRAF mutations and HR gene defects in PTC. Mutations in BRCA1, BRCA2, and FANCA genes, typically associated with thyroid tumors, were identified in the tissue of papillary thyroid cancer (PTC). A statistically significant correlation was found between the FANCA gene mutation (rs7195066) and the recurrent course of the PTC. The preliminary findings suggest a potential role for non-pathogenic BARD1 mutations in follicular adenoma. No significant association was found between genes involved in homologous recombination repair and the incidence of papillary thyroid carcinoma, suggesting that these genes may not play a major role in the development of this type of thyroid cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biochemistry and Molecular Biology Division, Siberian State Medical University, 2 Moskovsky Trakt, Tomsk 634050, Russia.
- Cancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, 5 Kooperativny Street, Tomsk 634050, Russia.
ORCID-Profile: Liudmila V Spirina, Svetlana Yu Chizhevskaya
Förderung
- the Russian Science Foundation
- Russian Science Foundation
Zitieren
APA
Spirina, L. V., Tsyganov, M. M., Chizhevskaya, S. Y., Tarasenko, N. V., & Bogdanova, V. A. (2025). Homologous Recombination in Thyroid Tumor Samples. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26199716
Vancouver
Spirina LV, Tsyganov MM, Chizhevskaya SY, Tarasenko NV, Bogdanova VA. Homologous Recombination in Thyroid Tumor Samples. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26199716
BibTeX
@article{Spirina2025,
author = {Spirina, Liudmila V and Tsyganov, Matvey M and Chizhevskaya, Svetlana Yu and Tarasenko, Natalia V and Bogdanova, Veronika A},
title = {Homologous Recombination in Thyroid Tumor Samples},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26199716}
}
EUVIMED